RGEN (STOCKS)
Repligen Corp
$130.870000
+0.280000 (+0.21%)
Prev close: $130.590000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Olivier Dominique Loeillot
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $7,382.64M
- Employees
- 1,778
- P/E (TTM)
- 143.76
- P/B (TTM)
- 3.50
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $763.34M |
| Benefits Costs and Expenses | $707.13M |
| Cost Of Revenue | $359.57M |
| Costs And Expenses | $698.81M |
| Gross Profit | $403.77M |
| Nonoperating Income/Loss | -$8.32M |
| Operating Expenses | $339.24M |
| Selling, General, and Administrative Expenses | $295.79M |
| Depreciation and Amortization | $79.80M |
| Research and Development | $55.71M |
| Operating Income/Loss | $64.53M |
| Income/Loss From Continuing Operations After Tax | $51.40M |
| Income/Loss From Continuing Operations Before Tax | $56.21M |
| Income Tax Expense/Benefit | $4.82M |
| Income Tax Expense/Benefit, Deferred | -$9.87M |
| Net Income/Loss | $51.40M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $51.40M |
| Net Income/Loss Available To Common Stockholders, Basic | $51.40M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $0.92 |
| Diluted Earnings Per Share | $0.90 |
| Basic Average Shares | 56,466,525 |
| Diluted Average Shares | 56,779,083 |
| Assets | $2.93B |
| Current Assets | $1.16B |
| Inventory | $179.26M |
| Other Current Assets | $982.10M |
| Noncurrent Assets | $1.77B |
| Fixed Assets | $173.46M |
| Intangible Assets | $368.19M |
| Other Non-current Assets | $1.23B |
| Liabilities | $825.31M |
| Current Liabilities | $126.21M |
| Accounts Payable | $34.66M |
| Wages | $26.28M |
| Other Current Liabilities | $65.27M |
| Noncurrent Liabilities | $699.10M |
| Long-term Debt | $546.59M |
| Other Non-current Liabilities | $152.52M |
| Equity | $2.11B |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $2.11B |
| Liabilities And Equity | $2.93B |
| Net Cash Flow From Operating Activities | $130.71M |
| Net Cash Flow From Operating Activities, Continuing | $130.71M |
| Net Cash Flow From Investing Activities | -$228.35M |
| Net Cash Flow From Investing Activities, Continuing | -$228.35M |
| Net Cash Flow From Financing Activities | -$15.72M |
| Net Cash Flow From Financing Activities, Continuing | -$15.72M |
| Net Cash Flow | -$113.37M |
| Net Cash Flow, Continuing | -$113.37M |
| Comprehensive Income/Loss | $84.93M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $84.93M |
| Other Comprehensive Income/Loss | $36.04M |